Transient Ischemic Attack clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 18 years and up
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
San Francisco, California and other locations
Our lead scientists for Transient Ischemic Attack research studies include Wade Smith, MD, PhD.